Abstract
Background: Despite recent advances in immunosuppressive therapy, up to 10% of patients with severe inflammatory bowel disease remain refractory to conventional treatment. Recent studies show that immune ablation by high-dose immunsuppression and autologous peripheral blood hematopoietic cell transplantation (aPBHCT) may efficiently induce long-lasting clinical remission in autoimmune disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
